Chih‐Long Chang

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 296 citations

Advanced Cervical Cancer, Cervical Cancer, Cervical Health +9

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 130 citations

Advanced Cervical Cancer, Cervical Cancer Management, Cervical Cancer +10

Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer

Chueh‐Yi Huang, Yuh‐Cheng Yang, Tze‐Chien Chen et al. · Journal of Cachexia Sarcopenia and Muscle · 2020 · 78 citations · Full text

Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer

Jie Lee, Jhen‐Bin Lin, Meng‐Hao Wu et al. · Journal of Cachexia Sarcopenia and Muscle · 2019 · 71 citations · Full text

Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes

Jie Lee, Jhen‐Bin Lin, Chih‐Long Chang et al. · Gynecologic Oncology · 2017 · 60 citations

Advanced Cervical Cancer, Cervical Cancer, Radiation Therapy +6